ÂÜÀòÂÒÂ×

Amber Perry currently serves as Manager of High-Throughput Screening and Compound Management at PTC Therapeutics, Inc., a position held since July 2021, after progressing from Associate Manager of HTS. Prior experience includes a lengthy tenure at Cibus US LLC from June 2005 to July 2021, where roles included Automation Platform Supervisor and Senior Research Associate. Amber Perry is pursuing a Master of Business and Science in Drug Discovery & Development at Rutgers University, with expected completion in December 2023, and holds a Bachelor of Science in Cell/Cellular and Molecular Biology from San Diego State University, earned in December 2018.